Quantinno Capital Management LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1759654 NEW YORK, NY

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,155,798

+$5,327,665 QoQ

Shares Held

69,499

+157.5% QoQ

Ownership

0.069%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Quantinno Capital Management LP holds $190,557,921 across 33 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	1,680,427	$40,212,618
2	ZTS	Zoetis Inc.	330,839	$39,108,478
3	TAK	Takeda Pharmaceutical Co Ltd	1,289,326	$23,878,317
4	VTRS	Viatris Inc	1,161,696	$15,694,512
5	UTHR	UNITED THERAPEUTICS Corp	21,135	$12,532,632
6	HLN	Haleon plc	1,221,499	$12,227,204
7	NBIX	Neurocrine Biosciences Inc This page	69,499	$9,155,798
8	RDY	Dr Reddys Laboratories Ltd	637,094	$8,823,751

All Filings in NBIX

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,155,798	69,499	+157.5%	Shares	Sole	2026-05-15
2025-12-31	$3,828,133	26,991	+66.6%	Shares	Sole	2026-02-17
2025-09-30	$2,274,857	16,205	+26.1%	Shares	Sole	2025-11-14
2025-06-30	$1,614,739	12,847	+21.1%	Shares	Sole	2025-08-14
2025-03-31	$1,173,134	10,607	+167.7%	Shares	Sole	2025-05-12
2024-12-31	$540,949	3,963	+77.0%	Shares	Sole	2025-02-14
2024-09-30	$257,977	2,239	+25.0%	Shares	Sole	2024-11-14
2024-06-30	$246,566	1,791	+9.4%	Shares	Sole	2024-08-14
2024-03-31	$225,775	1,637	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.